Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation

This publication has 25 references indexed in Scilit:

• SIROLIMUS REDUCES THE INCIDENCE OF ACUTE REJECTION EPISODES DESPITE LOWER CYCLOSPORINE DOSES IN CAUCASIAN RECIPIENTS OF MISMATCHED PRIMARY RENAL ALLOGRAFTS: A PHASE II TRIAL1
  Transplantation, 1999
• Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection
  Clinical and Experimental Immunology, 1997
• IMMUNOPHARMACOLOGY OF RAPAMYCIN
  Annual Review of Immunology, 1996
• The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
  The Journal of Experimental Medicine, 1992
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
  Cell, 1991
• CYCLOSPORINE, FK506, AND RAPAMYCIN
  Transplantation, 1990
• Announcements
  Omega, 1989
• RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTING
  The Lancet, 1989
• New antitumor substances of natural origin
  Cancer Treatment Reviews, 1981
• Inhibition of the immune response by rapamycin, a new antifungal antibiotic
  Canadian Journal of Physiology and Pharmacology, 1977